盐酸普拉克索结构式 
             
            
            
         | 
        常用名 | 盐酸普拉克索 | 英文名 | Pramipexole dihydrochloride | 
|---|---|---|---|---|
| CAS号 | 104632-25-9 | 分子量 | 284.249 | |
| 密度 | N/A | 沸点 | 378ºC at 760 mmHg | |
| 分子式 | C10H19Cl2N3S | 熔点 | 288-290ºC | |
| MSDS | 美版 | 闪点 | 182.4ºC | 
            盐酸普拉克索用途Pramipexole双盐酸盐是部分和完全的D2S,D2L,D3和D4受体激动剂, Ki分别为3.9,2.2,0.5和5.1 nM。  | 
    
| 中文名 | 盐酸普拉克索 | 
|---|---|
| 英文名 | pramipexole hydrochloride anhydrous | 
| 中文别名 | S(-)-2-氨基-6-正丙氨基-4,5,6,7-四氢苯并噻唑二盐酸盐 | (S)-普拉克索二盐酸化物 | 
| 英文别名 | 更多 | 
| 描述 | Pramipexole双盐酸盐是部分和完全的D2S,D2L,D3和D4受体激动剂, Ki分别为3.9,2.2,0.5和5.1 nM。 | 
|---|---|
| 相关类别 | |
| 参考文献 | 
| 沸点 | 378ºC at 760 mmHg | 
|---|---|
| 熔点 | 288-290ºC | 
| 分子式 | C10H19Cl2N3S | 
| 分子量 | 284.249 | 
| 闪点 | 182.4ºC | 
| 精确质量 | 283.067688 | 
| PSA | 79.18000 | 
| LogP | 4.15830 | 
| 外观性状 | 白色结晶粉末 | 
| 蒸汽压 | 6.49E-06mmHg at 25°C | 
| 储存条件 | Desiccate at RT | 
| 危害码 (欧洲) | Xi | 
|---|---|
| 危险品运输编码 | NONH for all modes of transport | 
| 海关编码 | 2934999090 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~84%  
                                            盐酸普拉克索 104632-25-9  | 
                                
| 文献:INSTYTUT FARMACEUTYCZNY Patent: WO2007/75095 A1, 2007 ; Location in patent: Page/Page column 7 ; | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~72%  
                                            盐酸普拉克索 104632-25-9  | 
                                
| 文献:Ravinder; Rajeswar Reddy; Panasa Reddy; Bandichhor, Rakeshwar Tetrahedron Letters, 2013 , vol. 54, # 36 p. 4908 - 4913 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~98%  
                                            盐酸普拉克索 104632-25-9  | 
                                
| 文献:Helm AG; CF Pharma Gyogyszergyarto Kft. Patent: EP1878731 A1, 2008 ; Location in patent: Page/Page column 11 ; | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~85%  
                                            盐酸普拉克索 104632-25-9  | 
                                
| 文献:Helm AG; CF Pharma Gyogyszergyarto Kft. Patent: EP1878731 A1, 2008 ; Location in patent: Page/Page column 11 ; | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            盐酸普拉克索 104632-25-9  | 
                                
| 文献:WO2011/21214 A2, ; | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            盐酸普拉克索 104632-25-9  | 
                                
| 文献:WO2011/21214 A2, ; | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            盐酸普拉克索 104632-25-9  | 
                                
| 文献:WO2011/21214 A2, ; | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            盐酸普拉克索 104632-25-9  | 
                                
| 文献:WO2011/21214 A2, ; | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            盐酸普拉克索 104632-25-9  | 
                                
| 文献:WO2011/21214 A2, ; | 
| 海关编码 | 2934999090 | 
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% | 
| 申报要素 | 品名, 成分含量, 用途 | 
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% | 
| 
                                    
                                    Pramipexole reduces parkinsonian tremor induced by pilocarpine infusion in the rat striatum.
                                    
                                    
                                     Pharmacol. Biochem. Behav. 131 , 1-5, (2015) Pramipexole is widely prescribed for the treatment of Parkinson's disease. This dopamine (DA) receptor agonist has a higher affinity for D3 over D2 receptors. We compared the effect of pramipexole to ...  | 
                                |
| 
                                    
                                    Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.
                                    
                                    
                                     PLoS ONE 10(3) , e0117698, (2015) Our recent study has indicated that a moderate lesion of the mesostriatal and mesolimbic pathways in rats, modelling preclinical stages of Parkinson's disease, induces a depressive-like behaviour whic...  | 
                                |
| 
                                    
                                    De novo expression of dopamine D2 receptors on microglia after stroke.
                                    
                                    
                                     J. Cereb. Blood Flow Metab. 35 , 1804-11, (2015) Dopamine is the predominant catecholamine in the brain and functions as a neurotransmitter. Dopamine is also a potent immune modulator. In this study, we have characterized the expression of dopamine ...  | 
                                
| 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N-propyl-, (6S)-, hydrochloride (1:2) | 
| (6S)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine Dihydrochloride | 
| (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride | 
| Pramipexole hydrochloride | 
| Pramipexole dihydrochloride | 
| MFCD00876894 | 
| (S)-Pramipexole Dihydrochloride | 
| (6S)-N-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine dihydrochloride | 
| (S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine dihydrochloride | 
| Pramipexole (dihydrochloride) |